Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions

S Wang, W Wu, X Lin, KM Zhang, QL Wu, M Luo… - Cell & Bioscience, 2023 - Springer
The most common site of metastasis in breast cancer is the bone, where the balance
between osteoclast-mediated bone resorption and osteoblast-mediated bone formation is …

Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques

AF Mavrogenis, P Altsitzioglou, S Tsukamoto… - Current Oncology, 2024 - mdpi.com
Biopsy is a pivotal component in the diagnostic process of bone and soft tissue tumors. The
objective is to obtain adequate tissue without compromising local tumor dissemination and …

Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation

DK Yadav, A Sharma, P Dube, S Shaikh… - Computers in Biology …, 2022 - Elsevier
Breast cancer (BC) is a malignancy that affects a large number of women around the world.
The purpose of the current study was to use bioinformatics analysis to uncover gene …

Integrated computational screening and liquid biopsy approach to uncover the role of biomarkers for oral cancer lymph node metastasis

S Shaikh, DK Yadav, K Bhadresha, RM Rawal - Scientific Reports, 2023 - nature.com
Cancer is an abnormal, heterogeneous growth of cells with the ability to invade surrounding
tissue and even distant organs. Worldwide, GLOBOCAN had an estimated 18.1 million new …

Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach

K Bhadresha, SP Kumar, J Brahmbhatt, C Patel… - Chemico-Biological …, 2022 - Elsevier
Poor prognosis and metastasis have been recognized as the major cause of breast cancer
related deaths worldwide. Recent experimental evidence has shown that Hsp90, the prime …

Genome-scan meta-analysis identifies potential biomarkers for hepatitis B and hepatitis C virus-associated hepatocellular carcinomas

H Motwani, M Patel, N Dixit, RM Rawal, SK Patel… - Human Gene, 2023 - Elsevier
Abstract Background Hepatocellular Carcinoma (HCC) is the most prevalent malignant
tumor with an elevated frequency of mortality. Around 80% of global HCC cases are caused …

[HTML][HTML] Liquid biopsies in primary and secondary bone cancers

A Ucci, N Rucci, M Ponzetti - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Liquid biopsies are a powerful tool to non-invasively analyze tumor phenotype and
progression as well as drug resistance. In the bone oncology field, liquid biopsies would be …

Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients

C Ceran Serdar, Ş Osmanlıoğlu - Turkish Journal of Biochemistry, 2023 - degruyter.com
Objectives This study aims to comprehensively evaluate extracellular vesicle (EV)-based
biomarkers circulating in body fluids with significant prognostic value in breast cancer …

Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine

DY Lu, S Putta, JY Che - BME Horizon, 2023 - ojs.gs-publishing.uk
mortality for all diseases worldwide [1, 2]. Furthermore, 70-90% cancer death is caused by
neoplasm metastasis. Cancer bone metastasis is one of the highest frequent cancer …